Invest in Russia — invest in Russian regions!
All news

Regulation 2.0: Stress test of the system from the pandemic to new challenges

16 June 2022
Регуляторика 2.0: Стресс-тест системы от пандемии к новым вызовам

The expert discussion ‘Regulation 2.0: Stress Test of the System from Pandemic to New Challenges’ was held on the opening day of the St. Petersburg International Economic Forum as part of the business programme of the ‘Ensuring Drug Security’ Russian Pharmaceutical Forum.

The drug circulation regulatory system faced new, unprecedented challenges in 2022, such as the risk of a changes in the cost of medicines and the protection of the national market against shortages of vital drugs due to the curtailed supply of original imported drugs.

The experience Russia has gained from the COVID-19 pandemic has strengthened its regulatory system and prompted the government to make quick and effective decisions that have proven that the development, registration, and commercial release of drugs can be significantly accelerated without compromising safety and quality. This experience should be adopted today and continued.

«The pharmaceutical industry has proven to be one of the most flexible amidst the coronavirus infection and was able to quickly restructure its processes to ensure the uninterrupted production and delivery of medicines in the required volume. Today, during these new challenges, we need to make the most of the tools to support the pharmaceutical industry, including based on the successful experience gained during the pandemic,» Federal Service for Surveillance in Healthcare (Roszdravnadzor) Director Alla Samoylova said.

Experts discussed how shortages of raw pharmaceutical materials and logistics problems are affecting the cost of finished products, what government measures to regulate and control costs could protect the interests of pharmaceutical manufacturers, pharmacy chains, and end consumers, whether the compulsory licensing system will be able to insure the Russian market in the event the supply of imported drugs decreases or their prices significantly increase, and how to maintain effective control and oversight activities and ensure the quality of medicines in the face of the new challenges?

The session was held with the support of the Promomed Group.

For more, see the full programme of the ‘Ensuring Drug Security’ Russian Pharmaceutical Forum on the official website of the event: